Story · Medicine & Biotech · Mind & Brain

Alzheimer's blood marker may help estimate cognitive impairment risk up to 10 years ahead

1 outlet · first reported by Medical Xpress on

A blood biomarker for Alzheimer's disease may help estimate a cognitively healthy person's risk of developing mild cognitive impairment or dementia over the next five or 10 years, according to a new Mayo Clinic study in JAMA Neurology. (Medical Xpress)

Coverage, in order

  1. Medical Xpress indie peer-reviewed
    Alzheimer's blood marker may help estimate cognitive impairment risk up to 10 years ahead

    A blood biomarker for Alzheimer's disease may help estimate a cognitively healthy person's risk of developing mild cognitive impairment or dementia over the next five or 10 years, according to a new Mayo Clinic study in JAMA Neurology.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.